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COVID-19 restrictions and increased 
risk of overdose for street-based 
people with opioid dependence in 
South Africa
To the Editor: The placement of street-based people in temporary 
shelters as part of South Africa (SA)’s lockdown efforts to mitigate 
the COVID-19 epidemic increases the risk of overdose among people 
who are dependent on heroin. The number of street-based heroin-
dependent people is unknown,[1] but many of the country’s estimated 
75 000 people who inject drugs live on the street and inject heroin,[2] 
and many more smoke it (known locally as nyaope, whoonga and 
unga).[3]
People with opioid dependence develop tolerance after repeated 
use, and an increased dose is essential to maintain a required effect. 
Tolerance reverses within several days of abstinence, and the opioid 
system up-regulates and resensitises to pre-use levels.[4] Failure to 
moderate dosing to accommodate reduced tolerance after periods of 
abstinence is a significant cause of overdose following release from 
prison or inpatient rehabilitation and after periods of drug supply 
interruption.[5] Globally, opioid overdoses are the leading cause of 
drug-related deaths, inducing respiratory depression and hypoxia 
that can be fatal.[6]
Opioid substitution therapy (OST), using methadone or 
buprenorphine at a correct dose as long-term maintenance, is the 
gold standard for managing opioid dependence.[7] OST improves 
health and reduces overdose mortality. Overdose is also mitigated 
through community awareness and training, and wide distribution 
of naloxone.[8]
Apart from efforts across Pretoria to provide access to OST as 
maintenance and one shelter in Durban providing methadone as 
part of managed withdrawal, the majority of the heroin-dependent 
population who remain in shelters will have an extended, involuntary 
period of abstinence.
Heroin is a potent physical and psychological analgesic and 
helps many people to endure the adverse conditions, hopelessness 
and stigma of living on the street.[9] Furthermore, there is a strong 
relationship between heroin dependence and adverse childhood 
events and trauma.[10] Without OST as maintenance, most heroin-
dependent people are likely to re-initiate heroin use once they return 
to their communities.[11]
After the lockdown in SA, the overdose risk will be elevated due 
to reduced tolerance and the concurrent use of other central nervous 
system depressants (e.g. alcohol and benzodiazepines).[12] The trauma 
of leaving a ‘formal’ safe shelter and ongoing drug criminalisation 
further increase overdose vulnerability.[13] The potential for poisoning 
from potent synthetic opioids, such as fentanyl and its analogues, in 
light of the changed drug market is unknown.[14]
To mitigate the risk of overdose in the time of COVID-19, we 
recommend: 
• That government funds the scaling up and access to OST at all 
shelters in locations where the capacity for OST initiation exists 
through partnership with civil society and academic institutions. 
People initiated onto OST during lockdown should be linked to 
ongoing maintenance therapy with access to psychosocial services 
once released.
• That government enables civil society and academic institutions 
to establish opioid overdose prevention programmes before 
the lockdown period ends, that focus on education and skills-
based training of people who use opioids. Additionally, increased 
community-based access to naloxone in health and substance use 
treatment centres and the provision of naloxone to OST clients, 
paired with appropriate administration training, is needed.
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